BIO

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. Bio-Rad's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.
CEO
Norman Schwartz
Employees
8000
Headquarters

1000 Alfred Nobel Dr
Hercules, California 94547-1811
Phone: 15107247000
www.bio-rad.com

News

Single-cell Analysis Market - Estimated To Experience A Hike In Growth By 2031 | Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Fluidigm Corporation
Nov 04, 2022 12:39pm

New York, According to a new market research report published by Global Insight Services Single-cell Analysis Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and


Source:OpenPR
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
Oct 31, 2022 12:30pm

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a Fireside Chat event during the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022, at 11:00 AM (PST). A link to a live webcast of the event will be available in the Investor Relations


Source:Wallstreet:Online
Bio-Rad Laboratories, Inc. (BIO) Q3 2022 Earnings Call Transcript
Oct 28, 2022 02:23am

Bio-Rad Laboratories, Inc. (NYSE:NYSE:BIO) Q3 2022 Earnings Conference Call October 27, 2022, 17:00 ET Company Participants Edward Chung - VP, IR Ilan Daskal - EVP & CFO Andrew Last -…


Source:Seeking Alpha
Bio-Rad Labs Non-GAAP EPS of $2.60 misses by $0.17, revenue of $680.8M misses by $1.9M
Oct 27, 2022 20:41pm

Bio-Rad Labs press release (BIO): Q3 Non-GAAP EPS of $2.60 misses by $0.17.Revenue of $680.8M (-8.9% Y/Y) misses by $1.9M.For the full-year 2022, the company continues to…


Source:Seeking Alpha
Repligen, Bio-Rad, life sciences tool makers down after Sartorius says COVID demand slows
Oct 19, 2022 17:53pm

Life Sciences tool makers including Repligen (RGEN) and Bio-Rad Laboratories (BIO) are down in Wednesday trading after competitor Sartorius (SARTF) said it was seeing "a swift…


Source:Seeking Alpha
Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?
Oct 14, 2022 16:26pm

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24%. However, in the longer term, BIO stock, with 65% returns from levels se


Source:Nasdaq
Will Bio-Rad & Qiagen Merge? I Can''t See Any Logic To This Deal (NYSE:BIO)
Oct 12, 2022 17:55pm

Rumors are circulating that life sciences/diagnostics companies Qiagen and Bio-Rad may merge. Read why a deal may face a difficult time getting off the ground.


Source:Seeking Alpha
Why Bio-Rad Laboratories'' Rumored $10 Billion Qiagen Buyout Looks Unlikely
Oct 11, 2022 16:04pm

A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day.


Source:Investor''s Business Daily
Qiagen N.V. May Merge with Bio-Rad Laboratories
Oct 11, 2022 12:04pm

Shares of Qiagen N.V. (NYSE:QGEN) gained 3.2%, while shares of Bio-Rad Laboratories (NYSE:BIO) were down 8.4% yesterday. The share price movement was followed by a Wall Street Journal news report that said both companies could potentially merge in a deal worth $10 billion approximately. Based in the Netherlands, QIAGEN NV is a holding company that provides sample and assay technology to transform biological samples into valuable molecular insights. Based in the U.S., Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications.


Source:TipRanks
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
Oct 11, 2022 11:53am

Bio-Rad Laboratories Inc (NYSE: BIO ) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN ), but any agreement isn''t likely for another few weeks or more, or it may not happen at all. A deal between Qiagen and Bio-Rad would be the latest tie-up in the medical-diagnostic market. The sector has grown as the pandemic helped increase demand for testing. According to the Wall Street Journal report , … Full story available on Benzinga.com


Source:Benzinga
US stocks closed lower, Dow Jones down 0.32%
Oct 11, 2022 03:15am

At the close of the New York Stock Exchange, the Dow Jones was down 0.32%, the S&P 500 was down 0.75% and the NASDAQ Composite was down 1.04%. Walgreens Boots Alliance Inc was the leading gainer in the Dow Jones Index today, up 1.32 points or 4.33% to close at 31.84. Merck & Company Inc rose 2.88 points or 3.29% to close at 90.48. Boeing Co rose 2.11 points or 1.63% to close at 131.90. The losers were Salesforce Inc, which shed 4.65 points or 3.09% to end the session at 145.64. Microsoft Corporation was up 2.13% or 4.99 points to close at 229.25, while Walt Disney Company was down 2.06% or 2.00 points to close at 95. 16. Leading gainers among the S&P 500 index components in today''s trading were Walgreens Boots Alliance Inc, which rose 4.33% to 31.84, Moderna Inc, which gained 3.44% to close at 123.42, and also shares of McCormick & Company Incorporated, which rose 3.30% to end the session at 75.86. The biggest losers were Wynn Resorts Limited, which shed 12.25% to close at 64.14. Shares of Bio-Rad Laboratories Inc shed 8.33% to end the session at 393.19.


Source:InstaForex
Biotech Firms Bio-Rad and Qiagen Discuss Major Merger
Oct 11, 2022 03:00am

It''s the circle of life for life-sciences companies. The California-based Bio-Rad Laboratories and the Netherlands-based Qiagen are deep in talks…


Source:The Motley Fool
Bio-Rad Laboratories In Talks To Merge With Qiagen: Report
Oct 11, 2022 01:58am

TOKYO (dpa-AFX) - Bio-Rad Laboratories Inc. (BIO) is in talks to merge with Qiagen NV (QGEN) in a deal worth more than $10 billion, the Wall Street Journal reported, citing people familiar with th…


Source:Finanz Nachrichten
Bio-Rad Labs and Qiagen in Combination Talks - WSJ By Investing.com
Oct 10, 2022 19:23pm

Bio-Rad Labs and Qiagen in Combination Talks - WSJ


Source:Investing.com
Bio-Rad Laboratories in discussions with Qiagen to merge - WSJ
Oct 10, 2022 18:18pm

Diagnostics company Bio-Rad Laboratories (BIO) is in talks with competitor Qiagen N.V. to combine, The Wall Street Journal reported.


Source:Seeking Alpha
UPDATE: Bio-Rad Labs in Talks to Combine with Qiagen - WSJ
Oct 10, 2022 18:15pm

https://www.investing.com/news/pro/update-biorad-labs-in-talks-to-combine-with-qiagen--wsj-432SI-2908597


Source:Investing.com
Diagnostics firm Bio-Rad in talks to merge with Qiagen – WSJ
Oct 10, 2022 18:14pm

California-based diagnostics company Bio-Rad Laboratories is in talks to merge with Qiagen NV , according to a Wall Street Journal report on Monday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Vinay Dwivedi)


Source:Financial Post
Bio-Rad Laboratories in Talks to Combine With Qiagen
Oct 10, 2022 18:03pm

Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.


Source:The Wall Street Journal
WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen
Oct 10, 2022 18:03pm

Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.


Source:The Wall Street Journal
Expansion of the Protein Assays Market Industry is Forecasted to Reach at Very High Rate in the Coming Years | Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories,
Oct 04, 2022 06:08am

The Protein Assays Market study combines a quantitative investigation of local markets with a novel viewpoint on the target market. The study includes information on the market''s size, as well as its strengths and weaknesses, important players, a sector overview,


Source:OpenPR
Steve Galt, formerly of Fishawack Health, joins Cambridge Healthcare Research as Chief Commercial Officer
Oct 03, 2022 18:06pm


Source:Kwhen Finance